Emerald Clinics hopes anonymous, real world patient data can help reduce apprehension among regulators and clinicians over the use of medical cannabis. Alternative healthcare provider Emerald Clinics is set to make its ASX debut next month and aims to shake up the medical world with its unique cannabinoid data platform. The company operates a network of clinics across Australia specialising in medical cannabis treatments and captures anonymous, high-quality real world data from its patients, which it claims has significant value and is in demand from licensed producers, regulators, insurers and prescribers. Emerald is seeking to raise at least $6 million and up to $8 million through the issue of 30-40 million shares at an issue price of $0.20 each. This offer indicates a market capitalisation of about $37-39 million upon completion. Bids are expected to close at the end of this week with Emerald set to begin trading on […]